Barrington Research analyst James Goss downgrades CuriosityStream (NASDAQ:CURI) from Outperform to Market Perform.
Analyst Ratings for G1 Therapeutics
Over the past 3 months, 7 analysts have published their opinion on G1 Therapeutics (NASDAQ:GTHX) stock. These analysts…